Breaking News
Sort by:
Top Post
Taysha Gene Therapies Announces First Patient Dosed with TSHA-102 in the REVEAL Phase 1/2 Trial for the Treatment of Rett Syndrome
Taysha Gene Therapies, a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene […]
Enterome Announces First Patient Dosed in a Phase 1/2 Trial with Second OncoMimics™ Vaccine, EO2463, in Non-Hodgkin Lymphoma
Enterome SA, a clinical stage biopharmaceutical company developing novel drugs based on its unique ability to […]
HIV Vaccine Trial HIV-CORE 0052 Starts at Oxford
The goal of the trial, known as HIV-CORE 0052, is to evaluate the safety, tolerability, […]
IntraOp Announces First Patients Enrolled in FLASH Clinical Trial
IntraOp Medical Corporation announced today that Lausanne University Hospital (CHUV, Switzerland) enrolled the first patients in the Impulse […]
Genoskin Launches ISR Platform®, the First Human Skin Ex Vivo Platform to Study Injection Site Reactions (ISR)
Genoskin, a biotechnology company that provides transformative platforms and tools leveraging human skin to test […]
New Soliqua ® Data Shows Improved Blood Sugar Control Without Weight Gain Versus Premixed Insulin
A new study of Soliqua (insulin glargine 100 Units/mL and lixisenatide, iGlarLixi) met its two […]
Medable Launches Digital Certification Program to Accelerate Adoption of Decentralized Clinical Trials
Medable Inc., the leading software platform for patient-centered drug development, today announced an industry-first digital certification […]
£64 Million Funding to Back UK-wide Plan to Strengthen Clinical Research Delivery
Better health outcomes through more effective and efficient research as seen throughout the pandemic Promoting […]
eTheRNA and VUB to Engineer Next Generation mRNA Therapeutics with TetraMix ®
eTheRNA immunotherapies NV (‘eTheRNA’, Niel, Belgium), a clinical-stage company developing mRNA-based immunotherapies for the treatment of […]
Kesimpta® (Ofatumumab) Data Show Long-term Preservation of IgG/IgM Levels and no Increased Risk of Serious Infections in People Living with Multiple Sclerosis
Today, Novartis disclosed new data showing mean IgG and IgM levels remain unchanged in adults […]
THREAD DESIGN Launch Will Maximize Effectiveness of Decentralized Clinical Trials (DCT)
THREAD, a technology and service provider enabling decentralized clinical trials (“DCT”), today announced the launch […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more